Simão C. Rodeia

Simão C. Rodeia

Auto-generated profile, based on publicly available information

Simão C. Rodeia

Medical Emergency Unit, Centro Hospitalar Universitário Lisboa Central, Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2016 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
ACAna Sofia Carvalho
Ana Sofia Carvalho
SRSimão C Rodeia
Simão C Rodeia
JSJoana Silvestre
Joana Silvestre
PPPedro Póvoa
Pedro Póvoa
Heat stroke (HS) is defined as a severe elevation of core body temperature along with central nervous system dysfunction. Exertional heat stroke (EHS) with acute liver failure (ALF) is a rare condition. The authors report the case of a 25-year-old man with a history of cognitive enhancers’ intake who developed hyperthermia and neurological impairment while running an outdoor marathon. The patient was cooled and returned to normal body temperature after 6 h. He subsequently developed ALF and was transferred to the intensive care unit. Over-the-counter drug intake may have been related to heat intolerance and contributed to the event. The patient was successfully treated with conservative measures. In the presence of EHS, it is crucial to act promptly with aggressive total body cooling, in order to prevent progression of the clinical syndrome. Liver function must also be monitored, since it can be a late organ dysfunction.

1 January 2020 in Autoimmunity Reviews
Verified
Journal Article
Closed access
BCBenjamin Chaigne
Benjamin Chaigne
SRSimao Rodeia
Simao Rodeia
NBNouria Benmostefa
Nouria Benmostefa
ABAlice Bérézné
Alice Bérézné
JAJérôme Authier
Jérôme Authier
LMLuc Mouthon
Luc Mouthon

2 December 2021 in Blood Purification
Verified
Journal Article
Open access
PDF file
SRSimão C. Rodeia
Simão C. Rodeia
FMFrancisca Lopes Martins
Francisca Lopes Martins
PFPhilip Fortuna
Philip Fortuna
LBLuís Bento
Luís Bento
Respiratory failure and systemic inflammation are paramount features of severe SARS-CoV-2 disease (COVID-19). Extracorporeal membrane oxygenation (ECMO) therapy has a potential role in patients with refractory disease. An inflammatory response due to blood contact with hemofilters, functioning as a synergic inflammatory stimulus, can lead to a hyperinflammatory state, relatable to cytokine release syndromes. After the first patient succumbed to a refractory vasodilatory shock believed to be due to hyperinflammatory state, a strategy of blood purification through cytokine adsorption therapy (CAT) with CytoSorb® was designed. In this case series, the authors describe the initial experience with such strategy. CAT was employed with no direct complications and helped controlling the inflammatory state, with all patients halting vasopressor support in 72 h and biomarker levels (C-reactive protein, ferritin, and interleukin-6) showing negative trends in most patients. Analysis of inflammatory biomarkers evolution highlighted 2 biomarker profiles related to the presence or absence of superinfection at the time of CAT implementation. In this case series of severe COVID-19 patients, 3 patients died – irreversible lung fibrosis, complications of critical hypoxemia before ECMO induction and complications of systemic anticoagulation were the causes. This case series aimed to contribute to the body of evidence substantiating CAT utilization in hyperinflammatory patients, namely, COVID-19 patients requiring ECMO rescue.

5 May 2023 in ASAIO Journal
Verified
Journal Article
Closed access
PCPedro Gaspar da Costa
Pedro Gaspar da Costa
SRSimão C. Rodeia
Simão C. Rodeia
PFPhilip Fortuna
Philip Fortuna